Cargando…

Evaluation of neuroendocrine markers in renal cell carcinoma

BACKGROUND: The purpose of the study was to examine serotonin, CD56, neurone-specific enolase (NSE), chromogranin A and synaptophysin by immunohistochemistry in renal cell carcinomas (RCCs) with special emphasis on patient outcome. METHODS: We studied 152 patients with primary RCCs who underwent sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ronkainen, Hanna, Soini, Ylermi, Vaarala, Markku H, Kauppila, Saila, Hirvikoski, Pasi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876076/ https://www.ncbi.nlm.nih.gov/pubmed/20462442 http://dx.doi.org/10.1186/1746-1596-5-28

Ejemplares similares

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2010)

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2011)

Identification of androgen-regulated genes in human prostate
por: VAARALA, MARKKU H., et al.
Publicado: (2012)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010
por: Laru, Lauri, et al.
Publicado: (2021)

Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer
por: Laru, Lauri, et al.
Publicado: (2021)

Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma
por: Honkavuori-Toivola, Maria, et al.
Publicado: (2013)

Claudins in lung diseases
por: Soini, Ylermi
Publicado: (2011)

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
por: Teppo, Hanna-Riikka, et al.
Publicado: (2017)

Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression
por: Jouppila-Mättö, Anna, et al.
Publicado: (2011)

Transcription factors zeb1, twist and snai1 in breast carcinoma
por: Soini, Ylermi, et al.
Publicado: (2011)

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
por: Isohookana, Joel, et al.
Publicado: (2015)

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
por: Berdel, Bozena, et al.
Publicado: (2012)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung
por: Kaarteenaho, Riitta, et al.
Publicado: (2010)

Snail promotes an invasive phenotype in lung carcinoma
por: Merikallio, Heta, et al.
Publicado: (2012)

Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity
por: Harju, Terttu, et al.
Publicado: (2008)

Neuroendocrine marker staining pattern categorization of small‐sized pulmonary large cell neuroendocrine carcinoma
por: Minami, Kazuhiro, et al.
Publicado: (2019)

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
por: Kallio, J P, et al.
Publicado: (2003)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer
por: Tuomarila, Marie, et al.
Publicado: (2014)

Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis
por: Huang, Rui, et al.
Publicado: (2020)

A Nomogram Model Based on Neuroendocrine Markers for Predicting the Prognosis of Neuroendocrine Carcinoma of Cervix
por: Jia, Mingzhu, et al.
Publicado: (2023)

Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas
por: Valkonen, Mari, et al.
Publicado: (2018)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

Treatment of renal angiomyolipoma: pooled analysis of individual patient data
por: Kuusk, Teele, et al.
Publicado: (2015)

CIP2A expression is increased in prostate cancer
por: Vaarala, Markku H, et al.
Publicado: (2010)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

Pulmonary Large Cell Carcinoma Expressing Neuroendocrine Markers: The Morphological, Biological, and Neuroendocrine Features of Their Cell Lines and Surgical Cases
por: Kasai, Kiyoshi, et al.
Publicado: (1992)

Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System
por: Xing, Jiazhang, et al.
Publicado: (2020)

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)
por: Sun, Xujie, et al.
Publicado: (2022)

An evaluation of dry eye symptoms and signs in a cohort of children with juvenile idiopathic arthritis
por: Kotaniemi, Kaisu M, et al.
Publicado: (2009)

Incidental Detection of Neuroendocrine Carcinoma of Rectum During Staging Workup of Renal Cell Carcinoma
por: Athiyappan, Kumaresh, et al.
Publicado: (2015)

Combined Papillary Renal Cell Carcinoma with Neuroendocrine Differentiation and Mucinous Tubular and Spindle Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2018)

Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma
por: Andreetti, Claudio, et al.
Publicado: (2022)

Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2023)

miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer
por: Fernandez, Serena, et al.
Publicado: (2014)

Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
por: Dong, Yunlong, et al.
Publicado: (2020)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
por: Sundquist, Elias, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a6csic6c8beus6v99iq85ivuag